Covid-19 Pan-Covid Study

Covid-19 research Pan-Covid

There is currently no known treatment for Covid-19. So far, over 30,000 people are taking part in a range of NIHR supported COVID-19 research studies across the UK.

Nichola Bale, Senior Research Midwife talks about a new Global registry of women aged between 18 and 50 who have had suspected or confirmed Covid-19 in pregnancy and their babies.
The study aims to better understand the effects of corona virus on women and their babies by compiling a global disease registry focussing on birth outcomes.

 

Video Transcript:

Hello I'm Nikki Bale and I am the local PI for the Pan-Covid study. The Pan-Covid study is a global registry of women aged between 18 and 50 who have had suspected or confirmed Covid-19 in pregnancy and their babies. Data will be collected retrospectively from January 2020 to March 2021 the study aims to better understand the effects of coronavirus on women and their babies by compiling a global disease registry. The focus will be on birth outcomes such as miscarriage, growth restriction, preterm labour, stillbirth and a vertical transmission between mother and baby. For entry into the study women need to have experienced symptoms of Covid-19 necessitating a period of self-isolation. They do not need to have been hospitalised or tested for the virus. Our Maternity Research Department would like to thank all the families that have taken part in the study so far.

Contact Research & Innovation

Research & Innovation
North Bristol NHS Trust
Floor 3 Learning & Research building
Southmead Hospital
Westbury-on-Trym
Bristol, BS10 5NB

Telephone: 0117 4149330
Email: research@nbt.nhs.uk